Manulife (Manufacturers Life Insurance)’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
+3,130
| New | +$260K | ﹤0.01% | 2440 |
|
|
2020
Q3 | – | Sell |
-60,129
| Closed | -$6.64M | – | 2940 |
|
|
2020
Q2 | $6.64M | Buy |
60,129
+55,185
| +1,116% | +$6.09M | 0.01% | 977 |
|
|
2020
Q1 | $383K | Buy |
+4,944
| New | +$383K | ﹤0.01% | 1955 |
|
|
2018
Q4 | – | Sell |
-19,608
| Closed | -$1.88M | – | 2850 |
|
|
2018
Q3 | $1.88M | Buy |
19,608
+9,219
| +89% | +$884K | ﹤0.01% | 1486 |
|
|
2018
Q2 | $989K | Sell |
10,389
-11,403
| -52% | -$1.09M | ﹤0.01% | 1896 |
|
|
2018
Q1 | $1.91M | Buy |
21,792
+14,850
| +214% | +$1.3M | ﹤0.01% | 1500 |
|
|
2017
Q4 | $589K | Buy |
6,942
+5,582
| +410% | +$474K | ﹤0.01% | 2212 |
|
|
2017
Q3 | $118K | Sell |
1,360
-5,769
| -81% | -$501K | ﹤0.01% | 3276 |
|
|
2017
Q2 | $550K | Buy |
7,129
+6,929
| +3,465% | +$535K | ﹤0.01% | 2214 |
|
|
2017
Q1 | $14K | Sell |
200
-26,294
| -99% | -$1.84M | ﹤0.01% | 3600 |
|
|
2016
Q4 | $1.57M | Buy |
26,494
+26,250
| +10,758% | +$1.55M | ﹤0.01% | 1457 |
|
|
2016
Q3 | $16K | Hold |
244
| – | – | ﹤0.01% | 3603 |
|
|
2016
Q2 | $13K | Buy |
244
+129
| +112% | +$6.87K | ﹤0.01% | 3595 |
|
|
2016
Q1 | $6K | Buy |
115
+1
| +0.9% | +$52 | ﹤0.01% | 3755 |
|
|
2015
Q4 | $8 | Hold |
114
| – | – | ﹤0.01% | 3584 |
|
|
2015
Q3 | $7 | Buy |
114
+33
| +41% | +$2 | ﹤0.01% | 3625 |
|
|
2015
Q2 | $7 | Buy |
+81
| New | +$7 | ﹤0.01% | 3630 |
|